Osprey Technology Acquisition Corp. (NYSE:SFTW) announced in an 8-K filing today that its shareholders approved its combination with satellite imaging company BlackSky Holdings, Inc. in a meeting held earlier today.
The filing disclosed that 21,375,376 shares were redeemed for a pro rata portion of the funds in the trust account at approximately $10.05 per share. As a result, approximately $214,906,385.05 million, or 65.9%, will be removed from the trust to pay the shareholders. SFTW saw high volume today with 3,082,404 shares traded throughout the day, representing approximately $30 million+ or 1/3 of the public float. SFTW closed today at $10.40.
Holders of 26,572,450 shares of SFTW’s stock were present at the meeting, representing 67.22% of the voting power. The business combination was overwhelmingly approved as it received 26,398,002 votes in favor of the proposal.
Although the 8-K did not give an exact timeline on the closing of the transaction, Osprey Technology expects it to be completely promptly. The company is expected to remain listed on the New York Stock Exchange with its common stock and warrants trading under the new ticker symbol “BKSY” and “BKSY.W” respectively.
The parties initially announced their $1.106 billion deal on February 18. Herndon V.A. based BlackSky is a a real-time Earth observation company leveraging the innovative performance and economics of small satellite constellations to deliver high revisit global monitoring solutions.
Just yesterday, BlackSky was awarded a five year contract by the National Geospatial-Intelligence Agency valued at $30 million.
ADVISORS
- Credit Suisse Securities (USA) LLC is acting as lead financial advisor and as capital markets advisor to BlackSky
- Credit Suisse Securities (USA) LLC acted as lead placement agent and Moelis & Company LLC also acted as placement agents in connection with the PIPE offering
- Moelis & Company LLC is acting as lead financial advisor and Union Square Advisors LLC is acting as capital markets and strategic advisor to Osprey
- PJT Partners LP is one of BlackSky’s financial advisors and a placement agent with respect to this transaction
- Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal advisor to BlackSky
- Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor to Osprey
- Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor to Credit Suisse Securities (USA) LLC
At the SPAC of Dawn Of the days with potential to shake up the market with news this week, today is the big one. Markets are currently anticipating a “near-zero” chance of any changes in the Fed’s rate-cut schedule coming out of today’s meeting. But, other news could come in a change in policy on...
The pace of de-SPACs making it to their lock-up expirations is set to roughly remain level with last month as May’s batch includes five companies and six sponsors set to be released. This group features a high number of Asia-based deals including its headline performer, SunCar Technology (NASDAQ:SDA), which last closed at $7.91. Earlier this...
DT Cloud Star (NASDAQ:DTSQU) filed an S-1 to raise $60 million as the second SPAC by its sponsor team, but this venture would be the 13th foray by underwriter Alliance Global Partners and the first under its new branding as AGP. However, three of those initial filings have subsequently been withdrawn. Nonetheless, AGP is offering...
At the SPAC of Dawn Tuesday brings another packed day in a packed week of potentially market-moving events and individual SPAC actions. The market today will take in the update on US consumer confidence readings as well as the employment cost index and Treasury’s decision on its quarterly refunding plans. An unusually large portion of...
Few target companies have gone through a greater amount of change through the course of their de-SPACing process than digital transformation firm Noventiq, which makes its latest update via a new investor presentation a particularly interesting read. When it initially announced its combination with Corner Growth (NASDAQ:COOL) in May 2023, Noventiq was still listed in...